Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 1/20 | 0.38 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.36 |
| ▸ | ENPP2 | Q13822 | 4/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | CA6 | P23280 | 1/20 | 0.33 |
| ▸ | CA5A | P35218 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.33 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.33 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.32 |
| ▸ | F11 | P03951 | 2/20 | 0.31 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | LPL | P06858 | 1/20 | 0.31 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.31 |
| ▸ | PLG | P00747 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL29955269 | 0.97 | HDAC1 (0.37) | HDAC1HDAC6HSP90AA1ENPP2KDM4E | |
| SCHEMBL28915991 | 0.87 | ALOX5AP (0.33) | HDAC1HDAC6 | |
| Pyrimidine SCHEMBL16208995 | 0.85 | HSP90AA1 (0.37) | HDAC1HDAC6HSP90AA1ENPP2KDM4E | |
| SCHEMBL15171311 | 0.79 | HDAC1 (0.35) | HDAC1HDAC6HSP90AA1MAP4K4 | |
| SCHEMBL7452989 | 0.74 | ENPP2 (0.39) | ENPP2CA4CA6CA5ACA7 | |
| SCHEMBL15915714 | 0.73 | FEN1 (0.54) | KDM4EALDH1A1 | |
| SCHEMBL16361627 | 0.72 | ENPP2 (0.33) | ENPP2CA4CA6CA5ACA7 | |
| SCHEMBL21469007 | 0.72 | HDAC8 (0.36) | ENPP2CA4CA6CA5ACA7 | |
| SCHEMBL154802 | 0.72 | CA2 (0.42) | ENPP2CA4CA6CA5ACA7 | |
| SCHEMBL1427905 | 0.72 | ENPP2 (0.42) | ENPP2CA4CA6CA5ACA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 639 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115873250-B | Black polyimide containing pyrrolopyrrole diketone structure and preparation method and application thereof | 湖南工业大学 | 2024-04-05 | — | — | CN | claimed |
| CN-117699779-A | Carbon dot solidifying agent and application thereof | 厦门大学 | 2024-03-15 | — | — | CN | claimed |
| CN-115873250-A | Black polyimide containing pyrrolopyrroledione structure and preparation method and application thereof | 湖南工业大学 | 2023-03-31 | — | — | CN | claimed |
| CN-113735864-B | D-benzothiadiazole-TB (-D) derivative and synthetic method and application thereof | 江苏师范大学 | 2022-04-15 | — | — | CN | claimed |
| CN-113735864-A | D-benzothiadiazole-TB (-D) derivative and synthetic method and application thereof | 江苏师范大学 | 2021-12-03 | — | — | CN | claimed |
| WO-2020254550-A1 | CARBON QUANTUM DOTS WITH IMPROVED OPTICAL PROPERTIES | UNIVERSITAT JAUME I (ES) | 2020-12-24 | — | — | WO | claimed |
| US-9980668-B2 | Photoluminescent nanostructure-based sensors | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2018-05-29 | — | — | US | claimed |
| CN-107188898-A | Process for preparing thienopyrimidine compounds | 霍夫曼-拉罗奇有限公司 | 2017-09-22 | — | — | CN | claimed |
| CN-104718212-B | Process for preparing thienopyrimidine compounds | 霍夫曼-拉罗奇有限公司 | 2017-06-16 | — | — | CN | claimed |
| EP-2906566-A1 | PROCESS FOR MAKING THIENOPYRIMIDINE COMPOUNDS | F. Hoffmann-La Roche AG (CH) | 2015-08-19 | — | — | EP | claimed |
| EP-2739977-A1 | PHOTOLUMINESCENT NANOSTRUCTURE-BASED SENSORS | Massachusetts Institute of Technology (US) | 2014-06-11 | — | — | EP | claimed |
| WO-2014056955-A1 | PROCESS FOR MAKING THIENOPYRIMIDINE COMPOUNDS | F. HOFFMANN-LA ROCHE AG (CH) | 2014-04-17 | — | — | WO | claimed |
| US-20130035567-A1 | PHOTOLUMINESCENT NANOSTRUCTURE-BASED SENSORS | NATIONAL SCIENCE FOUNDATION | 2013-02-07 | — | — | US | claimed |
| WO-2013019722-A1 | PHOTOLUMINESCENT NANOSTRUCTURE-BASED SENSORS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2013-02-07 | — | — | WO | claimed |
| EP-4747301-A2 | HYDROGELS EXHIBITING BORONATE ESTER-MEDIATED DRUG RELEASE | William Marsh Rice University (US) | 2026-05-27 | — | — | EP | disclosed |
| US-12637450-B2 | Tri-substituted aryl and heteroaryl derivatives as modulators of PI3-kinase and autophagy pathways | GLOBAL CANCER TECHNOLOGY INC. (US) | 2026-05-26 | — | — | US | disclosed |
| US-20260135164-A1 | LITHIUM SECONDARY BATTERIES CAPABLE OF SELF-POISONING | PROLOGIUM TECHNOLOGY CO., LTD. (TW) | 2026-05-14 | — | — | US | disclosed |
| WO-2008077597-A1 | 1-AMINOMETHYL- L- PHENYL- CYCLOHEXANE DERIVATIVES AS DDP-IV INHIBITORS | NOVARTIS AG (CH) | 2008-07-03 | — | — | WO | disclosed |
| WO-2008073785-A2 | PHOSPHOINOSITIDE 3-KINASE INHIBITOR COMPOUNDS AND METHODS OF USE | GENENTECH, INC. (US) | 2008-06-19 | — | — | WO | disclosed |
| WO-2008070740-A1 | PHOSPHOINOSITIDE 3-KINASE INHIBITOR COMPOUNDS AND METHODS OF USE | F.HOFFMANN-LA ROCHE AG (CH) | 2008-06-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260135164-A1 | LITHIUM SECONDARY BATTERIES CAPABLE OF SELF-POISONING | L3MBTL3, HAO2, LDHB | HDAC1 1959/4885HDAC6 1015/4885HSP90AA1 284/4885 |
| US-12637450-B2 | Tri-substituted aryl and heteroaryl derivatives as modulators of PI3-kinase and autophagy pathways | PIK3R4, PIK3R1, ATG7 | HDAC1 147/4885HDAC6 209/4885HSP90AA1 1340/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.